GR3024928T3 - Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions - Google Patents

Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions

Info

Publication number
GR3024928T3
GR3024928T3 GR970402569T GR970402569T GR3024928T3 GR 3024928 T3 GR3024928 T3 GR 3024928T3 GR 970402569 T GR970402569 T GR 970402569T GR 970402569 T GR970402569 T GR 970402569T GR 3024928 T3 GR3024928 T3 GR 3024928T3
Authority
GR
Greece
Prior art keywords
hydroxymethyl
acid derivatives
furazane
cardio
treatment
Prior art date
Application number
GR970402569T
Other languages
English (en)
Inventor
Karl Schoenafinger
Helmut Bohn
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR3024928T3 publication Critical patent/GR3024928T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR970402569T 1993-03-06 1997-10-03 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions GR3024928T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4307105A DE4307105A1 (de) 1993-03-06 1993-03-06 Hydroxymethylfurazancarbonsäurederivate
PCT/EP1994/000459 WO1994020478A1 (de) 1993-03-06 1994-02-18 Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen

Publications (1)

Publication Number Publication Date
GR3024928T3 true GR3024928T3 (en) 1998-01-30

Family

ID=6482135

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402569T GR3024928T3 (en) 1993-03-06 1997-10-03 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions

Country Status (21)

Country Link
US (1) US5486531A (el)
EP (1) EP0687256B1 (el)
JP (1) JP3578456B2 (el)
KR (1) KR960701029A (el)
CN (1) CN1043140C (el)
AT (1) ATE157660T1 (el)
AU (1) AU676718B2 (el)
CA (1) CA2155840C (el)
CZ (1) CZ284264B6 (el)
DE (2) DE4307105A1 (el)
DK (1) DK0687256T3 (el)
ES (1) ES2108977T3 (el)
FI (1) FI954138A (el)
GR (1) GR3024928T3 (el)
HU (1) HUT72641A (el)
IL (1) IL108856A (el)
PL (1) PL177603B1 (el)
RU (1) RU2134687C1 (el)
SK (1) SK280354B6 (el)
WO (1) WO1994020478A1 (el)
ZA (1) ZA941533B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4401150A1 (de) * 1994-01-17 1995-07-20 Cassella Ag Furazancarbonsäurederivate
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
PT1636215E (pt) * 2003-05-23 2008-04-29 Basilea Pharmaceutica Ag Furazanobenzimidazoles
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN112125865B (zh) * 2020-09-30 2022-08-12 北京理工大学 氧化呋咱化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012862A1 (de) * 1980-04-02 1981-10-08 Cassella Ag, 6000 Frankfurt Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE3047730A1 (de) * 1980-12-18 1982-07-15 Cassella Ag, 6000 Frankfurt 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen

Also Published As

Publication number Publication date
IL108856A (en) 1997-07-13
AU6141494A (en) 1994-09-26
PL310655A1 (en) 1995-12-27
CA2155840A1 (en) 1994-09-15
WO1994020478A1 (de) 1994-09-15
SK110095A3 (en) 1996-01-10
DK0687256T3 (da) 1998-03-30
FI954138A0 (fi) 1995-09-04
ATE157660T1 (de) 1997-09-15
EP0687256B1 (de) 1997-09-03
HUT72641A (en) 1996-05-28
RU2134687C1 (ru) 1999-08-20
FI954138A (fi) 1995-09-04
JPH08507299A (ja) 1996-08-06
HU9502603D0 (en) 1995-11-28
CZ284264B6 (cs) 1998-10-14
CN1119013A (zh) 1996-03-20
EP0687256A1 (de) 1995-12-20
JP3578456B2 (ja) 2004-10-20
SK280354B6 (sk) 1999-12-10
DE4307105A1 (de) 1994-09-08
CN1043140C (zh) 1999-04-28
KR960701029A (ko) 1996-02-24
ES2108977T3 (es) 1998-01-01
CZ228195A3 (en) 1995-12-13
PL177603B1 (pl) 1999-12-31
ZA941533B (en) 1994-10-06
CA2155840C (en) 2005-05-24
DE59403966D1 (de) 1997-10-09
AU676718B2 (en) 1997-03-20
US5486531A (en) 1996-01-23
IL108856A0 (en) 1994-06-24

Similar Documents

Publication Publication Date Title
ZA944884B (en) Derivatives of valproic acid amides and 2-valproenoic acid amides method of making and use thereof as anticonvulsant agent
ES8406472A1 (es) Procedimiento para preparar imidazolilalquiltien-2-il-tetrahidropiridazinas
HU9401950D0 (en) New aryl- and heteroaryl-ethylene derivatives and process for producing them
TW248559B (el)
AU1413592A (en) New polyiodated compounds, method of preparation, contrast product containing them
ATE28187T1 (de) Polyprenylcarbonsaeureamide und verfahren zu ihrer herstellung.
GR3024928T3 (en) Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
DE3476847D1 (en) A remedial or prophylactic agent for the treatment of seizures
NO941514D0 (el)
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
ES2107562T3 (es) Amidas de acidos alfa-aril-alfa-hidroxi-beta-imidazolinil-propanoicos.
DK0551653T3 (da) Enantiomeric pure cis-2-oxa-5,8-diazabicyclo(4.3.0)nonanes and process for their preparation
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
ES8203309A1 (es) Un metodo de inhibicion de las incrustaciones formadas por el agua y-o de los depositos arrastrados por el agua en los procesos de separacion de gas liquido.
ZA943338B (en) Preparation of symmetrical or unsymmetrical disubstituted n-cyanodithiominocarbonates